CLINICAL_TRIALS
trial_result
· 2022-09-16
Clinical Trial Update: Norepinephrine Transporter Blockade, Autonomic Failure (NETAF) [Phase 2]
Summary
Phase 2 clinical trial update for norepinephrine transporter blockade in neurogenic orthostatic hypotension has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Vanderbilt University Medical Center | Conditions: Neurogenic Orthostatic Hypotension | Phase 2 | Status: COMPLETED | Results posted: 2022-09-16